Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pessayre

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
Biochemical Pharmacology|April 15, 1976
Induction and inhibition of hepatic drug metabolizing enzymes by rifampinD Pessayre, P Mazel
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders]E Fréneaux, D Pessayre
Journal of Hepatology|January 1, 1997
Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokinesB Fromenty, D Pessayre
Pharmacology & Therapeutics|January 1, 1995
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicityB Fromenty, D Pessayre
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1979
[Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs]D Pessayre, J P Benhamou
Acta Gastro-Enterologica Belgica|September 1, 1978
[Drug-induced hepatits: the role of unstable metabolites (author's transl)]D Pessayre, J P Benhamou
Gastroenterologie Clinique Et Biologique|May 1, 1981
[Is it possible and desirable to detect the hepatotoxicity of a drug before its commercialization?]D Pessayre, J P Benhamou
British Medical Journal|May 19, 1979
Hepatotoxicity of erythromycin derivativesD Pessayre, J P Benhamou
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|October 1, 1979
[Drug-induced hepatitis caused by unstable metabolites]D Pessayre, J P Benhamou
Hepatology (Baltimore, Md.)|September 26, 1997
Ketoconazole-induced hepatotoxicityJ Bernuau, F Durand, D Pessayre
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
Biochemical Pharmacology|April 15, 1976
Induction and inhibition of hepatic drug metabolizing enzymes by rifampinD Pessayre, P Mazel
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders]E Fréneaux, D Pessayre
Journal of Hepatology|January 1, 1997
Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokinesB Fromenty, D Pessayre
Pharmacology & Therapeutics|January 1, 1995
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicityB Fromenty, D Pessayre
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1979
[Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs]D Pessayre, J P Benhamou
Acta Gastro-Enterologica Belgica|September 1, 1978
[Drug-induced hepatits: the role of unstable metabolites (author's transl)]D Pessayre, J P Benhamou
Gastroenterologie Clinique Et Biologique|May 1, 1981
[Is it possible and desirable to detect the hepatotoxicity of a drug before its commercialization?]D Pessayre, J P Benhamou
British Medical Journal|May 19, 1979
Hepatotoxicity of erythromycin derivativesD Pessayre, J P Benhamou
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|October 1, 1979
[Drug-induced hepatitis caused by unstable metabolites]D Pessayre, J P Benhamou
Hepatology (Baltimore, Md.)|September 26, 1997
Ketoconazole-induced hepatotoxicityJ Bernuau, F Durand, D Pessayre
Pageof 20